Study to measure optimum frequency of blood donation

June 15, 2012
Donated blood. Credit: NHSBT

A study commencing in the same week as World Blood Donor Day will determine whether blood can be safely collected more frequently than present practice.

Today, June 14, countries across the world will celebrate World Blood Day to raise awareness of the need for safe blood and blood products and to thank voluntary unpaid for their life-saving gifts of blood.

Also commencing this week is a landmark research study by a collaboration between NHS Blood and Transplant (NHSBT) and the Universities of Cambridge and Oxford, which will help determine whether blood can be safely collected more frequently than present practice.

As the UK population ages, the demand for blood and blood products is likely to increase. One approach to increase is to collect blood more frequently from existing donors. However, there is no strong scientific evidence to define the optimum interval between blood donations to maximise blood collections while maintaining donor well-being.

The study, which starts to recruit participants this week, aims not only to determine the optimal frequency of blood donations but also to define whether it is appropriate to tailor this interval to donors by their demographic, haematological, genetic and .

A joint England and Wales Special Health Authority, NHSBT provides a reliable, efficient supply of blood and associated services to the NHS in England and North Wales. NHSBT needs to collect up to 7,000 units of whole blood each day to meet demand from hospitals. This study, the first of its kind for NHSBT, will help determine whether donors can safely donate more frequently to help meet this demand.

Led by Professor John Danesh at the Department of Public Health and Primary Care at the University of Cambridge and Professor David Roberts at NHSBT, John Radcliffe Hospital, Oxford, the INTERVAL study will recruit up to 50,000 blood donors to a conducted within the framework of the UK’s NHSBT service.

“Limits are set for the intervals between donation frequency to minimise iron deficiency,” explained Cambridge researcher Dr Carmel Moore, who is coordinating the trial. “The present inter-donation intervals in England are 12 weeks for men and 16 weeks for women, yet in Europe donation frequency can be as frequent as every eight weeks. A decisive experiment is needed to determine whether blood can safely be given more frequently by the 1.4 million people who give blood each year in England.”

The trial involves NHSBT staff across the 25 permanent donation clinics in England and will enrol whole-blood donors to a two-year study. Men will be randomly assigned to 12-, 10- or 8-week inter-donation intervals and women to 16-, 14- or 12-week intervals. At the end of the study, the impact of donation intervals on the amount of blood collected and donors’ health and well-being will be assessed.

“In addition to evaluating the inter-donation interval, we are interested in assessing whether some people may be able to safely give blood more frequently and will be happy to do so,” added Dr Moore. “On the other hand, others may be more susceptible to iron deficiency with repeat . To prevent donors becoming iron deficient, haemoglobin levels are routinely measured before giving blood; if levels are too low the donor is asked to return at a later date. Being turned away can be a bad experience and lead to people’s unwillingness to donate again. Tailoring donation intervals to individuals would mean more susceptible donors could be invited to donate less frequently, which may improve donor satisfaction and retention.”

“The study’s key anticipated contribution to the NHSBT will be to provide evidence to inform long-term policies that improve the health and well-being of donors and ensure the supply of blood,” said Jane Pearson, Assistant Director – Nursing and Component Donation Services (NHSBT).

Professor Danesh added: “Contributing to broader public health research, an additional value of the project will be provided through the creation of a national epidemiological bioresource to study the health of donors.”

Explore further: Blood donation still safe for those with tattoos

Related Stories

Blood donation still safe for those with tattoos

May 20, 2011
The weather is finally starting to warm up, and people are breaking out the shorts, bathing suits and flip-flops.

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.